【正文】
接合和非接合 ? blaKPC兩側(cè)通常攜帶轉(zhuǎn)座子序列 ? 報(bào)道過的質(zhì)粒 blaKPC 常伴有 : ? 一般 β內(nèi)酰胺酶 ? 超廣譜 β內(nèi)酰胺酶 ? 氨基葡糖苷類耐藥 ? 質(zhì)粒介導(dǎo)的氟喹諾酮耐藥 SUMMARY ? 如果臨床菌株對(duì)第三、第四代頭孢菌素 “ R”, 厄他培南 ≥2μg/ml( 1921mm) *亞胺培南、美羅培南 24μg/ml ( 1621mm) 應(yīng)進(jìn)行改良 Hodge 試驗(yàn) ? 對(duì)碳?xì)涿赶╊惪股孛舾卸?Hodge 試驗(yàn) ( +)的菌株, CLSI建議:報(bào)告 MIC值,但不報(bào)告 “ S” 。 其它碳?xì)涿赶┟复嬖跁r(shí)試驗(yàn)也呈陽(yáng)性 ? 特異性 90% Lee et al. CMI, 7, 88102. 2022. PCR擴(kuò)增及測(cè)序 KPC結(jié)構(gòu)基因 ? 對(duì)上述細(xì)菌 PCR檢測(cè) KPC基因,無(wú)丙二酸鹽枸櫞酸桿菌( C1)、肺炎克雷伯菌( A1500)顯示948bp左右條帶,陽(yáng)性對(duì)照是浙江二院贈(zèng)送的產(chǎn)KPC2的肺炎克雷伯菌。波多黎各 兩株肺炎克雷伯菌的 RAPD分析 ? 對(duì)上海地區(qū)分離的肺炎克雷伯菌( A1500)和浙江地區(qū)分離的肺炎克雷伯菌( K1)做隨機(jī)擴(kuò)增的多態(tài)性 DNA( RAPD)分析,證明兩株菌株不是同一克隆型 疾病與治療 ? KPCproducing anisms have been implicated in a variety of infections including bacteremia, ventilatorassociated pneumonia, urinary tract infection, and central venous catheter infection. ? Selection of antibiotic therapy should be tailored to antimicrobial susceptibility results for agents outside the beta lactam and carbapenem classes. In addition, antibiotic susceptibility testing should be requested for tigecycline, colistin and aztreonam. 危險(xiǎn)因素 ? Use of broad spectrum cephalosporins and/or carbapenems is an important risk factor for the development of colonization or infection with KPCpro